← Briefing archive
Saturday, 25 July 2026

Oil Above $100 Cracks Sentiment: Five Straight Sessions of Losses as Earnings Bright Spots Struggle to Offset Macro Headwinds

Crude Shock Dominates the Week

Brent crude surging past $100 per barrel — driven by Houthi attacks on Red Sea shipping lanes, U.S.-Iran tensions, and Kazakhstan output disruptions — has emerged as the dominant force pressuring Indian equities. The Nifty 50 closed at 23,767.45 (-0.43%) and the Sensex at 76,059.77 (-0.43%) on Friday, extending a losing streak to five consecutive sessions, with the Nifty shedding 2.3% for the week — its steepest weekly decline since mid-May. For an oil-importing economy like India, crude at these levels threatens to widen the current account deficit, stoke domestic inflation, and compress margins across fuel-sensitive sectors, making energy geopolitics the single most important macro variable to monitor right now.

Q1 Earnings: A Tale of Two Halves

The Q1 FY27 earnings season delivered a distinctly mixed picture: commodity and financial names shone brightly while volume-sensitive and capital goods sectors disappointed. Hindustan Zinc delivered a standout quarter with net profit surging 145% YoY to ₹5,469 crore and revenue up 72% to ₹13,033 crore, aided by strong metal prices and record-low zinc cost of production since transitioning to underground mining. Tata Consumer Products posted a 28% YoY PAT rise to ₹427 crore with 12% revenue growth, Shriram Finance's net profit jumped 60% YoY to ₹3,447 crore, and SBI Life reported 22% PAT growth to ₹720 crore with value of new business climbing 29% — collectively signalling resilience in consumption, NBFC credit, and life insurance franchises. On the other side, ACC's profit plunged 61% to ₹147 crore on lower sales volumes and higher costs, and REC's net profit dipped 6% to ₹4,193 crore on lower interest income, underscoring that not all sectors are firing uniformly this quarter.

Metals and Infrastructure Score Big

SAIL reported a remarkable 138% YoY jump in net profit to ₹1,636 crore for Q1 FY27, with EBITDA rising 49% to ₹4,356 crore, even as the company moderated production due to geopolitical headwinds — a signal that price realisation rather than volume has been the primary earnings driver in metals. Welspun Corp's profit nearly tripled YoY to ₹1,048 crore, reflecting strong pipeline and infrastructure order execution. Lodha Developers reported its highest-ever quarterly profit, with net profit doubling to ₹1,373 crore and sales bookings rising 4% to ₹4,630 crore — management expressed confidence in sustaining a 20% profit CAGR. The metals and real estate results collectively point to pockets of durable earnings momentum even as broader market indices remain under pressure.

IT Divergence: HCL Bets on AI, Infosys Falters

NIFTY IT bucked the broader market weakness, gaining 0.82% to 28,767.95 — standing out as a relative bright spot on a day of broad-based selling. HCL Technologies announced a new AI data centre in Bhubaneswar in partnership with Sarvam and the Government of Odisha, signalling an aggressive push to capitalise on India's emerging AI infrastructure opportunity. In contrast, Infosys drew concern after a weak Q1 showing — weaker revenue growth, a guidance cut, and softer deal wins have raised questions about its FY27 trajectory, with analysts warning that AI-led pricing pressure could widen the gap between Infosys and larger peers. The divergence within IT merits close attention: the sector's headline index strength may be masking significant stock-specific dispersion.

Pharma Pressured by Trump Tariff Threat

Pharmaceutical stocks faced fresh selling pressure after U.S. President Donald Trump announced a phased tariff plan on imported generic medicines, directly threatening Indian pharma exporters who supply a significant share of U.S. generic drug demand. Abbott India led sector losses at nearly 3.7%, with Ajanta Pharma and Alembic Pharma among those declining up to 4%, according to Livemint. The phased nature of the tariff plan introduces a prolonged period of policy uncertainty for Indian generics players, affecting not just near-term revenue visibility but also longer-term capital allocation decisions around U.S.-facing manufacturing capacity. This development adds a sector-specific overhang on top of the broader macro concerns weighing on the market.

Financial Markets: Rupee Steadies, Forex Reserves Firm

The rupee recovered 18 paise to settle at 96.55 against the U.S. dollar after opening weaker at 96.81, providing some relief after a turbulent session where intraday volatility was driven by crude oil fears and global risk-off sentiment. India's forex reserves rose by $1.08 billion to $676.24 billion, driven by a $4.55 billion increase in foreign currency assets that more than offset a $3.48 billion decline in gold reserves — a sign of underlying external account resilience even during market turbulence. Separately, ICICI Bank priced a $1 billion five-year dollar bond — the largest such issuance by an Indian lender in nearly 14 years — at a tighter-than-expected spread, attracting $3 billion in bids, reflecting continued international investor confidence in India's premier private banking franchise. Bank Nifty diverged from the broader indices, gaining 0.18% to 56,693.5, suggesting that financials are being viewed with relative favour compared to the more macro-exposed sectors.

Private Sector Growth Hits Four-Year Low

India's composite PMI for July signals a meaningful deceleration, with private sector growth slipping to a four-year low driven by weaker domestic demand and a slowdown in services activity — both manufacturing and services saw declining new orders. This data point arrives at an uncomfortable moment: it suggests the domestic demand engine may be losing momentum precisely as external shocks from elevated crude oil prices and tariff uncertainty intensify. Firms reportedly increased inventories and purchasing volumes amid supply chain uncertainty, which could add a working capital burden even as top-line growth slows. Exports offered a rare bright spot, with international demand for Indian goods and services showing improvement — a nuance worth tracking as the global trade picture evolves.

IPO and Regulatory Developments to Watch

Manipal Health Enterprises' ₹9,275 crore IPO opens on July 29 with a price band of ₹560-590 per share; the Temasek-backed company, India's largest hospital chain by bed capacity, plans to use most of the proceeds to cut debt, creating balance sheet headroom for future acquisitions. Indo-MIM's IPO crossed 3.07x subscription on Day 2 with the NII category exceeding 8x, and the issue closes on July 27 — investor appetite for quality SME/mid-market offerings appears firm despite the weak secondary market backdrop. Caliber Mining and Logistics listed at an 18-19% premium over its IPO price before erasing some gains amid broader market weakness, illustrating the challenge of sustaining listing-day momentum in a risk-off environment. SEBI's ₹30.56 crore fine against the former Axis MF chief dealer and associates in a front-running case spanning September 2021 to March 2022 is a reminder of the regulator's ongoing focus on market integrity and surveillance — a structural positive for institutional trust in Indian markets over the long run. NSE is set to launch India's first domestic benchmark-based natural gas futures on July 27, a landmark step toward transparent, India-centric price discovery in a commodity that is increasingly central to the country's energy transition.

Sector Intelligence
Metals & Mining
Strength — Hindustan Zinc's 145% PAT surge to ₹5,469 crore and SAIL's 138% profit jump to ₹1,636 crore highlight strong price realisation; Welspun Corp's near-tripling of profits adds further momentum to the metals complex.
Pharmaceuticals
Pressure — Trump's phased tariff plan on imported generics hit Indian pharma exporters hard, with Abbott India down ~3.7% and peers falling up to 4%; policy uncertainty over U.S. market access is now a sector-level overhang.
Aviation & Energy-Sensitive
Pressure — IndiGo flagged a difficult Q1 citing skyrocketing fuel prices, with the West Asia escalation adding uncertainty; elevated crude oil above $100/barrel structurally pressures any sector with high fuel cost exposure.
Life Insurance & NBFCs
Strength — SBI Life's 22% PAT growth to ₹720 crore, with value of new business up 29% and protection segment premiums more than doubling, signals durable structural demand; Shriram Finance's 60% PAT jump to ₹3,447 crore reinforces NBFC credit resilience.
Cement
Pressure — ACC's 61% profit plunge to ₹147 crore on volume decline and higher costs reflects ongoing demand-cost squeeze in cement; premium product market share gains are a silver lining but insufficient to offset near-term earnings erosion.
Information Technology
Selective Strength — NIFTY IT rose 0.82% to 28,767.95 with HCL Technologies expanding its AI data centre footprint; however, Infosys faces scrutiny after a guidance cut and weak deal wins, making stock-level differentiation critical within the sector.
What To Watch
  • 1Crude oil price trajectory and any further geopolitical developments in the Red Sea or U.S.-Iran standoff — sustained $100+ Brent is the single biggest macro variable for Indian inflation, the rupee, and corporate margins heading into the week.
  • 2Manipal Health Enterprises IPO opening on July 29 (price band ₹560-590) — subscription trends across HNI, QIB, and retail categories will serve as a real-time barometer of institutional risk appetite in a stressed secondary market environment.
  • 3NSE's launch of India's first domestic natural gas futures on July 27 — monitor initial price discovery, open interest build-up, and whether domestic gas prices diverge meaningfully from international benchmarks, with implications for gas utilities and city gas distribution companies.
  • 4Continuation of Q1 FY27 earnings season — management commentary on crude cost pass-through, U.S. tariff impact guidance from pharma companies, and demand outlook statements from consumer-facing businesses will be critical for recalibrating FY27 earnings estimates across sectors.

INFORMATIONAL PURPOSES ONLY. NOT INVESTMENT ADVICE. CONSULT A SEBI-REGISTERED ADVISER BEFORE INVESTING.

Read today's briefing →